Compounds > phenylalanyl-prolyl-arginine-chloromethyl ketone
Page last updated: 2024-09-03

phenylalanyl-prolyl-arginine-chloromethyl ketone and Disease Models, Animal

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Disease Models, Animal in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's4 (44.44)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Cui, G; Gaut, JP; Goette, M; Hu, L; Palekar, RU; Vemuri, C; Wickline, SA; Zhang, H1
Jallouk, AP; Myerson, JW; Palekar, RU; Pan, H; Wickline, SA1
Carlson, RW; Chilton, SM; Hadden, TJ; Schaeffer, RC1
Frey, L; Hancock, T; Hollenbach, S; Lin, PH; Needham, K; Sinha, U; Wolf, D; Wong, A1
Hollenbach, SJ; Ku, P; Lin, PH; Malinowski, J; Marlowe, CK; Scarborough, RM; Sinha, U; Wong, PW; Zhu, BY1
Castellino, FJ; Merz, JL; Noria, F; Raymond, S; Rosen, ED; Sandoval-Cooper, M; Shulman, A; Zollman, A1
Borm, A; Hirsh, J; Klement, P; Maraganore, J; Weitz, J; Wilson, G1
Broersma, RJ; Heminger, EF; Kutcher, LW1
Agnelli, G; Cosmi, B; Nenci, GG; Pascucci, C1

Other Studies

9 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Disease Models, Animal

ArticleYear
Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury.
    American journal of physiology. Renal physiology, 2015, Apr-01, Volume: 308, Issue:7

    Topics: Acute Kidney Injury; Amino Acid Chloromethyl Ketones; Animals; Cells, Cultured; Creatinine; Cysteine Proteinase Inhibitors; Disease Models, Animal; Endothelial Cells; Inflammation; Magnetite Nanoparticles; Male; Mice, Inbred C57BL; Reperfusion Injury; Thrombin

2015
Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:3

    Topics: Amino Acid Chloromethyl Ketones; Animals; Antithrombins; Apolipoproteins E; Atherosclerosis; Blood Coagulation; Capillary Permeability; Carotid Artery Injuries; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Humans; Inflammation Mediators; Magnetic Resonance Spectroscopy; Male; Mice, Knockout; Nanoparticles; Plaque, Atherosclerotic; Signal Transduction; Thrombin; Thrombosis; Time Factors

2016
Pulmonary fibrin microembolism with Echis carinatus venom in dogs: effects of a synthetic thrombin inhibitor.
    Journal of applied physiology: respiratory, environmental and exercise physiology, 1984, Volume: 57, Issue:6

    Topics: Amino Acid Chloromethyl Ketones; Animals; Body Water; Disease Models, Animal; Dogs; Fibrin; Fibrinogen; Hemodynamics; Leukocyte Count; Lung; Platelet Count; Pulmonary Embolism; Respiration; Thrombin; Viper Venoms

1984
A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis.
    Thrombosis and haemostasis, 1994, Volume: 71, Issue:3

    Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Animals; Bleeding Time; Blood Coagulation; Copper; Disease Models, Animal; Drug Evaluation, Preclinical; Factor V; Factor X; Factor Xa; Fibrinolytic Agents; Gossypium; Heparin; Humans; Molecular Sequence Data; Rabbits; Thrombin; Thrombolytic Therapy; Thrombosis; Vena Cava, Inferior

1994
Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.
    European journal of pharmacology, 2000, Apr-21, Volume: 395, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Antithrombins; Arteriovenous Shunt, Surgical; Bleeding Time; Disease Models, Animal; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemostatics; Heparin; Male; Oligopeptides; Rabbits; Serine Proteinase Inhibitors; Thiazoles; Thrombin; Thrombosis; Venous Thrombosis

2000
Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi.
    The American journal of pathology, 2001, Volume: 158, Issue:5

    Topics: Amino Acid Chloromethyl Ketones; Animals; Antithrombins; Blood Coagulation; Blood Platelets; Blood Vessels; Disease Models, Animal; Fibrinolytic Agents; Fluorescent Dyes; Lasers; Mice; Mice, Inbred C57BL; Microscopy, Electron; Peptides, Cyclic; Platelet Aggregation Inhibitors; Rose Bengal; Sulfoxides; Thrombosis; Time Factors

2001
The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model.
    Thrombosis and haemostasis, 1992, Jul-06, Volume: 68, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Animals; Arterial Occlusive Diseases; Disease Models, Animal; Heparin; Hirudin Therapy; Male; Molecular Sequence Data; Partial Thromboplastin Time; Peptides; Rats; Rats, Inbred Strains; Regional Blood Flow; Thrombin; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator

1992
The effect of thrombin inhibition in a rat arterial thrombosis model.
    Thrombosis research, 1991, Nov-15, Volume: 64, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Animals; Blood Platelets; Carotid Artery Thrombosis; Disease Models, Animal; Ferrous Compounds; Fibrin; Heparin; Male; Rats; Rats, Inbred Strains; Thrombin; Thrombocytopenia

1991
Effects of therapeutic doses of heparin on thrombolysis with tissue-type plasminogen activator in rabbits.
    Blood, 1990, Nov-15, Volume: 76, Issue:10

    Topics: Amino Acid Chloromethyl Ketones; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa; Fibrin; Heparin; Hirudins; Rabbits; Recombinant Proteins; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator

1990